vs
通用电气医疗（GEHC）与通用磨坊（GIS）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是通用磨坊的1.2倍（$5.7B vs $4.9B），通用电气医疗净利率更高（10.3% vs 8.5%，领先1.8%），通用电气医疗同比增速更快（7.1% vs -7.2%），过去两年通用电气医疗的营收复合增速更高（10.7% vs -2.4%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
通用磨坊是美国知名跨国消费食品企业，主营品牌包装食品的生产与营销，产品通过零售渠道面向大众发售。公司发源于明尼阿波利斯市密西西比河畔的圣安东尼瀑布区域，最初以大型面粉加工业务闻名，现总部位于明尼阿波利斯市郊的明尼苏达州金谷市。
GEHC vs GIS — 直观对比
营收规模更大
GEHC
是对方的1.2倍
$4.9B
营收增速更快
GEHC
高出14.3%
-7.2%
净利率更高
GEHC
高出1.8%
8.5%
两年增速更快
GEHC
近两年复合增速
-2.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.7B | $4.9B |
| 净利润 | $588.0M | $413.0M |
| 毛利率 | 39.7% | 34.8% |
| 营业利润率 | 14.5% | 15.0% |
| 净利率 | 10.3% | 8.5% |
| 营收同比 | 7.1% | -7.2% |
| 净利润同比 | -18.4% | -48.1% |
| 每股收益（稀释后） | $1.28 | $0.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEHCGIS
| Q4 25 | $5.7B | $4.9B | ||
| Q3 25 | $5.1B | $4.5B | ||
| Q2 25 | $5.0B | $4.6B | ||
| Q1 25 | $4.8B | $4.8B | ||
| Q4 24 | $5.3B | $5.2B | ||
| Q3 24 | $4.9B | $4.8B | ||
| Q2 24 | $4.8B | $4.7B | ||
| Q1 24 | $4.7B | $5.1B |
净利润GEHCGIS
| Q4 25 | $588.0M | $413.0M | ||
| Q3 25 | $446.0M | $1.2B | ||
| Q2 25 | $486.0M | $294.0M | ||
| Q1 25 | $564.0M | $625.6M | ||
| Q4 24 | $721.0M | $795.7M | ||
| Q3 24 | $470.0M | $579.9M | ||
| Q2 24 | $428.0M | $557.5M | ||
| Q1 24 | $374.0M | $670.1M |
毛利率GEHCGIS
| Q4 25 | 39.7% | 34.8% | ||
| Q3 25 | 38.7% | 33.9% | ||
| Q2 25 | 39.6% | 32.4% | ||
| Q1 25 | 42.1% | 33.9% | ||
| Q4 24 | 42.8% | 36.9% | ||
| Q3 24 | 41.7% | 34.8% | ||
| Q2 24 | 41.4% | 35.8% | ||
| Q1 24 | 40.9% | 33.5% |
营业利润率GEHCGIS
| Q4 25 | 14.5% | 15.0% | ||
| Q3 25 | 12.7% | 38.2% | ||
| Q2 25 | 13.1% | 11.1% | ||
| Q1 25 | 13.2% | 18.4% | ||
| Q4 24 | 15.1% | 20.6% | ||
| Q3 24 | 13.9% | 17.2% | ||
| Q2 24 | 12.6% | 16.5% | ||
| Q1 24 | 11.6% | 17.9% |
净利率GEHCGIS
| Q4 25 | 10.3% | 8.5% | ||
| Q3 25 | 8.7% | 26.7% | ||
| Q2 25 | 9.7% | 6.5% | ||
| Q1 25 | 11.8% | 12.9% | ||
| Q4 24 | 13.6% | 15.2% | ||
| Q3 24 | 9.7% | 12.0% | ||
| Q2 24 | 8.8% | 11.8% | ||
| Q1 24 | 8.0% | 13.1% |
每股收益（稀释后）GEHCGIS
| Q4 25 | $1.28 | $0.78 | ||
| Q3 25 | $0.98 | $2.22 | ||
| Q2 25 | $1.06 | $0.53 | ||
| Q1 25 | $1.23 | $1.12 | ||
| Q4 24 | $1.58 | $1.42 | ||
| Q3 24 | $1.02 | $1.03 | ||
| Q2 24 | $0.93 | $0.98 | ||
| Q1 24 | $0.81 | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $683.4M |
| 总债务越低越好 | $10.0B | $12.2B |
| 股东权益账面价值 | $10.4B | $9.3B |
| 总资产 | $36.9B | $32.5B |
| 负债/权益比越低杠杆越低 | 0.96× | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资GEHCGIS
| Q4 25 | $4.5B | $683.4M | ||
| Q3 25 | $4.0B | $952.9M | ||
| Q2 25 | $3.7B | $363.9M | ||
| Q1 25 | $2.5B | $521.3M | ||
| Q4 24 | $2.9B | $2.3B | ||
| Q3 24 | $3.5B | $468.1M | ||
| Q2 24 | $2.0B | $418.0M | ||
| Q1 24 | $2.6B | $588.6M |
总债务GEHCGIS
| Q4 25 | $10.0B | $12.2B | ||
| Q3 25 | $10.3B | $12.2B | ||
| Q2 25 | $10.3B | $12.7B | ||
| Q1 25 | $8.8B | $11.8B | ||
| Q4 24 | $9.0B | $12.4B | ||
| Q3 24 | $10.3B | $11.4B | ||
| Q2 24 | $9.2B | $11.3B | ||
| Q1 24 | $9.3B | $11.0B |
股东权益GEHCGIS
| Q4 25 | $10.4B | $9.3B | ||
| Q3 25 | $10.0B | $9.5B | ||
| Q2 25 | $9.7B | $9.2B | ||
| Q1 25 | $9.2B | $9.3B | ||
| Q4 24 | $8.4B | $9.2B | ||
| Q3 24 | $8.3B | $9.3B | ||
| Q2 24 | $7.8B | $9.4B | ||
| Q1 24 | $7.4B | $9.4B |
总资产GEHCGIS
| Q4 25 | $36.9B | $32.5B | ||
| Q3 25 | $36.1B | $33.0B | ||
| Q2 25 | $35.5B | $33.1B | ||
| Q1 25 | $33.6B | $32.7B | ||
| Q4 24 | $33.1B | $33.4B | ||
| Q3 24 | $33.9B | $31.8B | ||
| Q2 24 | $31.9B | $31.5B | ||
| Q1 24 | $32.2B | $30.9B |
负债/权益比GEHCGIS
| Q4 25 | 0.96× | 1.31× | ||
| Q3 25 | 1.03× | 1.29× | ||
| Q2 25 | 1.06× | 1.38× | ||
| Q1 25 | 0.95× | 1.28× | ||
| Q4 24 | 1.06× | 1.35× | ||
| Q3 24 | 1.24× | 1.23× | ||
| Q2 24 | 1.18× | 1.20× | ||
| Q1 24 | 1.25× | 1.17× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $819.3M |
| 自由现金流经营现金流 - 资本支出 | — | $675.7M |
| 自由现金流率自由现金流/营收 | — | 13.9% |
| 资本支出强度资本支出/营收 | 2.4% | 3.0% |
| 现金转化率经营现金流/净利润 | — | 1.98× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流GEHCGIS
| Q4 25 | — | $819.3M | ||
| Q3 25 | — | $397.0M | ||
| Q2 25 | $94.0M | $611.6M | ||
| Q1 25 | $250.0M | $531.9M | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $624.2M | ||
| Q2 24 | $-119.0M | $863.7M | ||
| Q1 24 | $419.0M | $943.1M |
自由现金流GEHCGIS
| Q4 25 | — | $675.7M | ||
| Q3 25 | — | $287.5M | ||
| Q2 25 | $8.0M | $391.4M | ||
| Q1 25 | $98.0M | $428.0M | ||
| Q4 24 | — | $989.6M | ||
| Q3 24 | — | $483.9M | ||
| Q2 24 | $-183.0M | $575.2M | ||
| Q1 24 | $274.0M | $751.4M |
自由现金流率GEHCGIS
| Q4 25 | — | 13.9% | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | 0.2% | 8.6% | ||
| Q1 25 | 2.1% | 8.8% | ||
| Q4 24 | — | 18.9% | ||
| Q3 24 | — | 10.0% | ||
| Q2 24 | -3.8% | 12.2% | ||
| Q1 24 | 5.9% | 14.7% |
资本支出强度GEHCGIS
| Q4 25 | 2.4% | 3.0% | ||
| Q3 25 | 2.1% | 2.4% | ||
| Q2 25 | 1.7% | 4.8% | ||
| Q1 25 | 3.2% | 2.1% | ||
| Q4 24 | 1.9% | 3.1% | ||
| Q3 24 | 1.9% | 2.9% | ||
| Q2 24 | 1.3% | 6.1% | ||
| Q1 24 | 3.1% | 3.8% |
现金转化率GEHCGIS
| Q4 25 | — | 1.98× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | 0.19× | 2.08× | ||
| Q1 25 | 0.44× | 0.85× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 1.08× | ||
| Q2 24 | -0.28× | 1.55× | ||
| Q1 24 | 1.12× | 1.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
GIS
| Snacks | $1.0B | 21% |
| Convenient Meals | $827.0M | 17% |
| Cereal | $791.2M | 16% |
| Dough | $720.9M | 15% |
| Pet | $698.7M | 14% |
| Baking Mixes And Ingredients | $556.0M | 11% |
| Super Premium Ice Cream | $175.8M | 4% |
| Other Product | $73.3M | 2% |
